Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Pfizer’s COVID pill reportedly offered no measurable benefit for adults 40 to 65, according to a study published on Wednesday.

The Israeli study was conducted among 109,000 patients who were 40 years old or older.

READ MORE
 

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Understanding Bible Prophecy: Your Questions Answered (Encore Edition)

Join us as we talk about two things we’re not supposed…
Read more

Fauci: There Won’t be a Federal Mandate for Vaccine Passports

Dr. Anthony Fauci claimed that it is highly unlikely for…
Read more

New York to Implement Vaccine Passport

New York is the very first state to roll out the IBM digital…
Read more